13.84MMarket Cap-0.10P/E (TTM)
4.6055High4.3000Low194.75KVolume4.5700Open4.7000Pre Close862.95KTurnover6.08%Turnover RatioLossP/E (Static)3.21MShares84.813652wk High1.15P/B13.81MFloat Cap1.800152wk Low--Dividend TTM3.20MShs Float1236.0000Historical High--Div YieldTTM6.50%Amplitude1.8000Historical Low4.4310Avg Price1Lot Size
Cingulate Stock Forum
📊⚡️📊
📊⚡️📊
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Positive
Working capital increased by $19.5M from December 2023
Raised $12.5M in capital during Q3 2024
Net loss decreased by 46% YoY to $3.2M
R&D expenses reduced by $2.5M YoY
Secured European patents for CTx-1301 in up to 30 territories
Regained Nasdaq compliance with $1.00 minimum bid requirement
Negative
Accumulated deficit increa...
via @Lnova 👌
No comment yet